Mineralys Therapeutics, Inc.

Direct answer

Mineralys Therapeutics, Inc. is publicly traded on NASDAQ under the ticker MLYS.

Mineralys Therapeutics, Inc. (MLYS) is a pioneering biopharmaceutical company currently advancing through clinical trials. Its primary focus lies in creating innovative treatments for high blood pressure and its related cardiovascular complications. The company's leading investigational drug is lorundrostat. This exclusive, orally administered compound functions as a highly targeted aldosterone synthase inhibitor,...

Can you invest in Mineralys Therapeutics, Inc.?

Yes. Mineralys Therapeutics, Inc. trades publicly on NASDAQ as MLYS.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Mineralys Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.